These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
53 related items for PubMed ID: 7887936
1. Cell-cycle-dependent modulation of EGF-receptor-mediated signaling. Newberry EP, Pike LJ. Biochem Biophys Res Commun; 1995 Mar 08; 208(1):253-9. PubMed ID: 7887936 [Abstract] [Full Text] [Related]
3. EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells. MacLeod CL, Luk A, Castagnola J, Cronin M, Mendelsohn J. J Cell Physiol; 1986 Apr 08; 127(1):175-82. PubMed ID: 3007537 [Abstract] [Full Text] [Related]
4. Epidermal growth factor stimulation of phosphatidylinositol 3-kinase during wound closure in rabbit corneal epithelial cells. Zhang Y, Akhtar RA. Invest Ophthalmol Vis Sci; 1997 May 08; 38(6):1139-48. PubMed ID: 9152233 [Abstract] [Full Text] [Related]
5. Epidermal growth factor modifies cell cycle control in A431 human squamous carcinoma cells damaged by ionizing radiation. Laderoute KR, Ausserer WA, Knapp AM, Grant TD, Sutherland RM. Cancer Res; 1994 Mar 15; 54(6):1407-11. PubMed ID: 8137238 [Abstract] [Full Text] [Related]
6. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Chen HW, Huang HC. Br J Pharmacol; 1998 Jul 15; 124(6):1029-40. PubMed ID: 9720770 [Abstract] [Full Text] [Related]
7. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Song L, Turkson J, Karras JG, Jove R, Haura EB. Oncogene; 2003 Jul 03; 22(27):4150-65. PubMed ID: 12833138 [Abstract] [Full Text] [Related]
8. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression. Ahmad N, Gali H, Javed S, Agarwal R. Biochem Biophys Res Commun; 1998 Jun 18; 247(2):294-301. PubMed ID: 9642119 [Abstract] [Full Text] [Related]
10. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation. Lipson KE, Pang L, Huber LJ, Chen H, Tsai JM, Hirth P, Gazit A, Levitzki A, McMahon G. J Pharmacol Exp Ther; 1998 May 25; 285(2):844-52. PubMed ID: 9580635 [Abstract] [Full Text] [Related]
11. Down-regulation of epidermal growth factor receptor-signaling pathway by binding of GRP78/BiP to the receptor under glucose-starved stress conditions. Cai B, Tomida A, Mikami K, Nagata K, Tsuruo T. J Cell Physiol; 1998 Nov 25; 177(2):282-8. PubMed ID: 9766525 [Abstract] [Full Text] [Related]
12. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Ram TG, Ethier SP. Cell Growth Differ; 1996 May 25; 7(5):551-61. PubMed ID: 8732665 [Abstract] [Full Text] [Related]
13. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation. Léotoing L, Manin M, Monté D, Baron S, Communal Y, Lours C, Veyssière G, Morel L, Beaudoin C. J Mol Endocrinol; 2007 Aug 25; 39(2):151-62. PubMed ID: 17693613 [Abstract] [Full Text] [Related]
14. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity. Arita Y, Buffolino P, Coppock DL. Exp Cell Res; 1998 Aug 01; 242(2):381-90. PubMed ID: 9683525 [Abstract] [Full Text] [Related]
15. EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway. Chiu T, Santiskulvong C, Rozengurt E. Am J Physiol Gastrointest Liver Physiol; 2005 Feb 01; 288(2):G182-94. PubMed ID: 15358595 [Abstract] [Full Text] [Related]
16. Maitotoxin, a calcium channel activator, inhibits cell cycle progression through the G1/S and G2/M transitions and prevents CDC2 kinase activation in GH4C1 cells. Van Dolah FM, Ramsdell JS. J Cell Physiol; 1996 Jan 01; 166(1):49-56. PubMed ID: 8557775 [Abstract] [Full Text] [Related]
17. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. Zi X, Grasso AW, Kung HJ, Agarwal R. Cancer Res; 1998 May 01; 58(9):1920-9. PubMed ID: 9581834 [Abstract] [Full Text] [Related]
18. Modulation of cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction pathways. Ray G, Dhar G, Van Veldhuizen PJ, Banerjee S, Saxena NK, Sengupta K, Banerjee SK. Biochemistry; 2006 Mar 21; 45(11):3703-13. PubMed ID: 16533053 [Abstract] [Full Text] [Related]
19. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc. Nass SJ, Dickson RB. Clin Cancer Res; 1998 Jul 21; 4(7):1813-22. PubMed ID: 9676860 [Abstract] [Full Text] [Related]
20. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity. Gardner DP, Shimizu N. J Cell Physiol; 1994 Feb 21; 158(2):245-55. PubMed ID: 8106561 [Abstract] [Full Text] [Related] Page: [Next] [New Search]